fda glp-1 compounding enforcement news is moving to restrict mass-marketed compounded products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger to protect patients from unverified Compounded Semaglutide & Tirzepatide 2025:
Description
Portion-control options in c-stores appealing to GLP-1 consumer.
Firms, smooths, and improves skin texture with advanced peptides
A more mindful, wellness-forward approach to GLP-1 use
GLP-1 medications have benefits and risks for fertility patients
My take: GLP-1RAs may become more than metabolic drugs, but oncology needs prospective cancer-outcome data before calling this prevention
Animal and human studies published in English language were included
